111 related articles for article (PubMed ID: 22525724)
21. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo anti-melanoma action of metformin.
Janjetovic K; Harhaji-Trajkovic L; Misirkic-Marjanovic M; Vucicevic L; Stevanovic D; Zogovic N; Sumarac-Dumanovic M; Micic D; Trajkovic V
Eur J Pharmacol; 2011 Oct; 668(3):373-82. PubMed ID: 21806981
[TBL] [Abstract][Full Text] [Related]
23. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
24. Phosphoethanolamine induces caspase-independent cell death by reducing the expression of C-RAF and inhibits tumor growth in human melanoma model.
Mambelli LI; Teixeira SF; Jorge SD; Kawamura B; Meneguelo R; Barbuto JAM; de Azevedo RA; Ferreira AK
Biomed Pharmacother; 2018 Jul; 103():18-28. PubMed ID: 29635124
[TBL] [Abstract][Full Text] [Related]
25. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.
Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM
Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.
Mijatovic S; Maksimovic-Ivanic D; Mojic M; Timotijevic G; Miljkovic D; Mangano K; Donia M; Di Cataldo A; Al-Abed Y; Cheng KF; Stosic-Grujicic S; Nicoletti F
J Cell Physiol; 2011 Jul; 226(7):1803-12. PubMed ID: 21506111
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and identification of a novel napthalamide-isoselenocyanate compound NISC-6 as a dual Topoisomerase-IIα and Akt pathway inhibitor, and evaluation of its anti-melanoma activity.
Karelia DN; Sk UH; Singh P; Gowda ASP; Pandey MK; Ramisetti SR; Amin S; Sharma AK
Eur J Med Chem; 2017 Jul; 135():282-295. PubMed ID: 28458134
[TBL] [Abstract][Full Text] [Related]
28. The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo.
Djerf Severinsson EA; Trinks C; Gréen H; Abdiu A; Hallbeck AL; Stål O; Walz TM
Biochem Biophys Res Commun; 2011 Oct; 414(3):563-8. PubMed ID: 21982771
[TBL] [Abstract][Full Text] [Related]
29. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
31. Synthetic phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase.
Ferreira AK; Meneguelo R; Marques FL; Radin A; Filho OM; Neto SC; Chierice GO; Maria DA
Biomed Pharmacother; 2012 Oct; 66(7):541-8. PubMed ID: 22902646
[TBL] [Abstract][Full Text] [Related]
32. Targeting melanoma with dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors.
Marone R; Erhart D; Mertz AC; Bohnacker T; Schnell C; Cmiljanovic V; Stauffer F; Garcia-Echeverria C; Giese B; Maira SM; Wymann MP
Mol Cancer Res; 2009 Apr; 7(4):601-13. PubMed ID: 19372588
[TBL] [Abstract][Full Text] [Related]
33. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
34. The FGF2-binding peptide P7 inhibits melanoma growth in vitro and in vivo.
Yu Y; Gao S; Li Q; Wang C; Lai X; Chen X; Wang R; Di J; Li T; Wang W; Wu X
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1321-8. PubMed ID: 22481251
[TBL] [Abstract][Full Text] [Related]
35. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
36. FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression.
Jeong K; Murphy JM; Rodriguez YAR; Kim JS; Ahn EE; Lim SS
Biochem Biophys Res Commun; 2019 Feb; 509(4):1034-1040. PubMed ID: 30660359
[TBL] [Abstract][Full Text] [Related]
37. A drug-like imidazole-benzothiazole conjugate inhibits malignant melanoma by stabilizing the c-MYC G-quadruplex.
Wu TY; Huang Q; Huang ZS; Hu MH; Tan JH
Bioorg Chem; 2020 Jun; 99():103866. PubMed ID: 32330737
[TBL] [Abstract][Full Text] [Related]
38. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
[TBL] [Abstract][Full Text] [Related]
39. [Inhibition of PDK1 gene expression in esophageal cancer EC9706 cells by RNA interference and its effect on their malignant biological behavior].
Yu J; Chen KS; Li YN; Yang J; Zhao L
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):410-4. PubMed ID: 21875479
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
